Platelet interaction with bioactive lipids formed by mild oxidation of low-density lipoprotein

Area of Science:

• Cardiovascular Biology
• Lipid Metabolism
• Thrombosis Research

Background:

• Oxidation of low-density lipoprotein (LDL) produces pro-inflammatory and pro-thrombotic mediators.
• Mildly oxidized LDL (mox-LDL) and minimally modified LDL (mm-LDL) accumulate in atherosclerotic lesions.
• Elevated levels of electronegative LDL are observed in high-risk cardiovascular patients.

Purpose of the Study:

• To investigate the role of oxidized LDL in platelet activation and aggregation.
• To identify specific lipids within oxidized LDL responsible for platelet stimulation.
• To elucidate the signaling pathways involved in oxidized LDL-induced platelet responses.

Main Methods:

• Analysis of LDL oxidation products.
• Platelet aggregation assays using native and oxidized LDL.
• Identification of lipid mediators using biochemical techniques.
• Investigation of G-protein coupled receptor (GPCR) and Rho/Rho kinase signaling pathways.

Main Results:

• Mox-LDL and mm-LDL, but not native LDL, induce platelet shape change and aggregation.
• LDL oxidation generates platelet-stimulatory lipids including lysophosphatidic acid (LPA).
• LPA was identified as the primary lipid responsible for platelet activation by mox-LDL, mm-LDL, and mox-HDL.
• Platelet activation occurs via stimulation of G-protein coupled LPA receptors and Rho/Rho kinase signaling.

Conclusions:

• Oxidized LDL, particularly mox-LDL and mm-LDL, activates platelets through lipid mediators like LPA.
• LPA-mediated platelet activation contributes to arterial thrombus formation and increased thrombogenicity in cardiovascular disease.
• Targeting LPA signaling pathways may offer therapeutic strategies for cardiovascular diseases.